A cost-based comparison of quarantine strategies for new emerging diseases

Mathematical Biosciences and Engineering

Volumn 7, Issue 3, 2010, Pages 687-717

  Mubayi, Anuj ^a,b,e   Zaleta, Christopher Kribs ^b   Martcheva, Maia ^c   Castillo Chávez, Carlos ^a,d  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d SANTA FE INSTITUTE   (United States)

^e PREVENTION RESEARCH CENTER   (United States)

Author keywords

Contact tracing; Cost effectiveness analysis; Isolation; Quarantine; Reproductive number; SARS

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIC; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; PUBLIC HEALTH; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HUMANS; MODELS, ECONOMIC; PUBLIC HEALTH; QUARANTINE; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 77954571676     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2010.7.687     Document Type: Article

References (59)

1. S. Allan, "Quarantine Isolation and Other Legal Issues From the Sars Experience: Concerns for Local Health Officials," NACCHO E-newsletter, Feb. (2004).
2. H. T. Bank and C. Castillo-Chavez (eds.), "Bioterrorism: Mathematical Modeling Applications in Homeland Security," SIAM, Philadelphia, 2003.
3. C. T. Bauch, J. O. Lloyd-Smith, M. P. Coffee and A. P. Galvani, Dynamically modeling SARS and other newly emerging respiratory illnesses: Past, Present, and Future, Epidemiology, 16 (2005), 791-801.
4. R. Bayer, C. Levine and S. M. Wolf, HIV antibody screening: An ethical framework for evaluating proposed programs, JAMA, 256 (1986), 1768-1774.
5. J. H. Beigel, J. Farrar, A. M. Han, F. G. Hayden, R. Hyer, M. D. de Jong, et al., Avian influenza a (H5N1) infection in humans: The writing committee of the world health organization (WHO) consultation on human influenza A/H5, N. Engl. J. Med., 353 (2005),1374-1385.
6. D. M. Bell, "World Health Organization Working Group on Prevention of International and Community Transmission of SARS. Public Health Interventions and SARS Spread, 2003," Emerg. Infect. Dis., (2004).
7. W. C. Black, The CE plane: A graphic representation of cost-effectiveness, Medical Decision Making, 10 (1990), 212-214.
8. M. L. Brandeau, G. S. Zaric and A. Richter, Resource allocation for control of infectious diseases in multiple independent populations: Beyond cost-effectiveness analysis, Journal of Health Economics, 22 (2003), 575-598
9. F. Brauer and C. Castillo-Chávez, "Mathematical Models in Population Biology and Epidemiology," Texts in Applied Mathematics, 40, Springer-Verlag, New York, 2001.
10. C. Castillo-Chávez, B. Song and J. Zhang, An epidemic model with virtual mass transportation: The case of smallpox in a large city, in bioterrorism: Mathematical modeling applications in homeland security, SIAM Frontiers in Applied Mathematics, (2003), 173-197.
11. C. Castillo-Chávez, C. Castillo-Garsow and A. A. Yakubu, Mathematical models of isolation and quarantine, JAMA, 290 (2003), 2876-2877.
12. C. Castillo-Chávez and Z. Feng, Mathematical models for the disease dynamics of tuberculosis, advances in mathematical population dynamics - molecules, cells, and man, (O. , D. Axelrod, M. Kimmel, (eds), World Scientific Press (1998), 629-656.
13. 0 and its role on global stability, in mathematical approaches for emerging and re-emerging infectious diseases, Part I, IMA, 125, Springer-Verlag, New York (2002), 224-250.
14. G. Chowell, C. Castillo-Chávez, P. W. Fenimore, C. M. Kribs-Zaleta, L. Arriola and J. M. Hyman, Model parameters and outbreak control for SARS, EID, 10 (2004), 1258-1263.
15. G. Chowell, P. W. Fenimore, M. A. Castillo-Garsow and C. Castillo-Chávez, SARS outbreaks in Ontario, Hong Kong and Singapore: The role of diagnosis and isolation as a control mechanism, Journal of Theoretical Biology, 224 (2003), 1-8.
16. L. Coudeville, A. Van Rie, D. Getsios, J. J. Caro, P. Crpey and V. H. Nguyen, Adult vaccination strategies for the control of pertussis in the United States: An economic evaluation including the dynamic population effects, PLoS One, 4: (2009), e6284. doi: 10.1371/journal.pone.0006284
17. R. A. Cox, C. Conquest, C. Mallaghan and R. R. Marples, Major outbreak of methicillinresistant Staphylococcus aureus caused by a new phage type (EMRSA-16), J. Hosp. Infect., 29 (1995), 87-106.
18. S. Del Valle, H. Hethcote, J. M. Hyman and C. Castillo-Chavez, Effects of behavioral changes in a smallpox attack model, Mathematical Biosciences, 195 (2005), 228-251.
19. C. A. Donnelly, A. C. Ghani, G. M. Leung, A. J. Hedley, C. Fraser, S. Riley, et al., Epidemiological determinants of spread of casual agent of severe acute respiratory syndrome in Hong Kong, Lancet, 361 (2003), 1761-1766.
20. W. J. Edmunds, G. F. Medley and D. J. Nokes, Evaluating the cost-effectiveness of vaccination programmes: A dynamic perspective, Stat. Med., 18 (1999), 3263-3282
21. M. Eichner, Case isolation and contact tracing can prevent the spread of smallpox, American Journal of Epidemiology, 158 (2003), 118-128.
22. E. H. Elbasha, E. J. Dasbach and R. P. Insinga, A multi-type HPV transmission model, Bull. Math. Biol., 70 (2008), 2126-2176.
23. M. Erdem, "Epidemic in Structured Populations with Isolation and Cross-Immunity," PhD Thesis, Department of Mathematics and Statistics, Arizona State University, (2007).
24. Z. Feng and H. Thieme, Recurrent outbreaks of childhood diseases revisited: the impact of isolation, Mathematical Biosciences, 128 (1995), 93-129.
25. P. E. Fine, The interval between successive cases of an infectious disease, Am. J. Epidemiol., 158 (2003), 1039-1047.
26. L. O. Gostin, R. Bayer and A. L. Fairchild, Ethical and legal challenges posed by severe acute respiratory syndrome: Implications for the control of severe infectious disease threats, JAMA, 290 (2003), 3229-3237.
27. A. G. Gupta, C. A. Moyer and D. T. Stern, The economic impact of quarantine: SARS in Toronto as a case study, Journal of Infection, 50 (2005), 386-393.
28. H. Hethcote, M. Zhein and L. Shengbing, Effects of quarantine in six endemic models for infectious diseases, Mathematical Biosciences, 180 (2002), 141-160.
29. Y.-H. Hsieh, C. W. S. Chen, S.-B. Hsu, SARS outbreak, Taiwan, 2003, Emerging Infectious Diseases, 10 (2004), 201-206.
30. Y.-H. Hsieh, C. C. King, C. W. S. Chen, M. S. Ho, S. B. Hsu and Y. C. Wu, Impact of quarantine on the 2003 SARS outbreak: A retrospective modeling study, J. Theoretical Biology, 244 (2007), 729-736.
31. J. M. Hyman, J. Li and E. A. Stanley, Modeling the impact of random screening and contact tracing in reducing the spread of HIV, Mathematical Biosciences, 181 (2003), 17-54.
32. "Hong Kong in Figures 2006 Edition," Census and Statistics Department Hong Kong Special Administrative Region.
33. M. Isekedjian, J. H. Walker, G. De Serres and T. R. Einarson, Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Quebec, Canada, Pediatr Drugs, 7 (2005), 123-136.
34. J. J. Kim, M. Brisson, W. J. Edmunds, S. J. Goldie, Modeling cervical cancer prevention in developed countries, Vaccine, 26 Suppl. 10 (2008), K76-K86.
35. D. Klinkenberg, C. Fraser, H. Heesterbeek, The effectiveness of contact tracing in emerging epidemics, PLoS ONE, 1 (2006), e12. doi:10.1371/ journal.pone.0000012
36. C. M Kribs-Zaleta and J. X. Velasco-Hernández, A simple vaccination model with multiple endemic states, Mathematical Biosciences, 164 (2000), 183-201.
37. S. H. Lee, The SARS epidemic in Hong Kong-a human calamity in the 21st century, Methods Inf. Med., 44 (2005), 293-298.
38. M. L. Lee, C. J. Chen, I. J. Su, K. T. Chen, C. C. Yeh, C. C. King, et al., Use of quarantine to prevent transmission of severe acute respiratory syndrome-Taiwan, 2003, CDC Morb Mortal Wkly Rep, 52 (2003), 680-683.
39. Y. S. Leo, M. Chen, B. H. Heng, C. C. Lee, N. Paton, B. Ang, et al., Severe acute respiratory syndrome - Singapore, 2003, CDC Morb. Mortal Wkly. Rep., 52 (2003), 405-411.
40. G. M. Leung, A. J. Hedley, L.-M. Ho, P. Chau, O. O. L. Wong, T. Q. Thach, et al., The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients, Annals of Internal Medicine, 141 (2004) 662-673.
41. S. Mehtar, Y. J. Drabu and F. Mayet, Expenses occurred during a 5-week epidemic of methicillin-resistant Staphylococcus aureus, J. Hosp. Infect., 13 (1989), 199-220.
42. A. T. Newall, P. Beutels, J. G.Wood, W. J. Edmunds and C. R. MacIntyre, Cost-effectiveness analyses of human papillomavirus vaccination, Lancet. Infect. Dis., 7 (2007), 289-296.
43. M. Nuño, Z. Feng, M. Martcheva and C. Castillo-Chavez, Dynamics of two-strain influenza with isolation and partial cross-immunity, SIAM Journal on Applied Mathematics, 65 (2005), 964-982.
44. P. L. Ooi, S. Lim and S. K. Chew, Use of quarantine in the control of SARS in Singapore, Am. J. Infect Control, 33 (2005), 252-257.
45. S. Riley, C. Fraser, C. A. Donnelly, A. C. Ghani, L. J. Abu-Raddad, A. J. Hedley, et al., Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions, Science, 300 (2003), 1961-1966.
46. "SARS Expert Committee, SARS in Hong Kong: From Experience to Action," Report of Hong Kong SARS Expert Committee, 2003. Available from: http://www.sars-expertcom.gov.hk/english/reports/reports.html.
47. F. Sassi, Calculating QALYs, comparing QALY and DALY calculations, Health Policy and Planning, 21 (2006), 402-408
48. R. Schabas, Severe acute respiratory syndrome: Did quarantine help?, The Canadian Journal of Infectious Diseases & Medical Microbiology, 15 (2004), 204.
49. D. C. Snyder and D. P. Chin, Cost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default, Am. J. Respir. Crit. Care. Med., 160 (1999), 582-586.
50. J. Speakman, F. Gonzalez-Martin and T. Perez, Quarantine in Severe Acute Respiratory Syndrome (SARS) and other emerging infectious diseases, Journal of Law, Medicine & Ethics, 31 (2003), 63-64.
51. T. Svoboda, B. Henry, L. Shulman, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto, N. Engl. J. Med., 350 (2004), 2352-2361.
52. A. V. Taira, C. P. Neukermans and G. D. Sanders, Evaluating human papillomavirus vaccination programs, Emerg Infect Dis [serial on the Internet] (2004) Nov.
53. C. C. Tan, SARS in Singapore-key lessons from an epidemic, Ann. Acad. Med. Singapore, 35 (2006), 345-349.
54. H. R. Thieme, Asymptotically autonomous differential equations in the plane, Rocky Mountain J. Math., 24 (1994), 351-380.
55. H. R. Thieme, "Mathematics in Population Biology," Princeton Series in Theoretical and Computational Biology, Princeton University Press, Princeton and Oxford, 2003, 568 pp..
56. P. Van den Driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Mathematical Biosciences, 180 (2002), 29-48.
57. R. Welte, M. Postma, R. Leidl and M. Kretzschmar, Costs and effects of chlamydial screening: Dynamic versus static modeling, Sexually Transmitted Diseases, 32 (2005), 474-483.
58. D. Wonderling, R. Gruen and N. Black, Introduction to health economics, Open University Press, Mc Graw - Hill Education, United Kingdom, 2005, 230-242.
59. L.-I. Wu and Z. Feng, Homoclinic bifurcation in an SIQR model for childhood disease, Journal of Differential Equations, 168 (2000), 150-167.